UK markets close in 4 hours 41 minutes

Hikma Pharmaceuticals PLC (HKMPY)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
49.000.00 (0.00%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 5.32B
Enterprise value 6.29B
Trailing P/E 28.82
Forward P/E 12.17
PEG ratio (5-yr expected) 2.41
Price/sales (ttm)1.89
Price/book (mrq)2.47
Enterprise value/revenue 2.19
Enterprise value/EBITDA 11.39

Trading information

Stock price history

Beta (5Y monthly) 0.40
52-week change 3-8.84%
S&P500 52-week change 319.61%
52-week high 356.63
52-week low 342.23
50-day moving average 349.75
200-day moving average 348.34

Share statistics

Avg vol (3-month) 3547
Avg vol (10-day) 3100
Shares outstanding 5110.94M
Implied shares outstanding 6110.54M
Float 8154.67M
% held by insiders 10.00%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41.44
Forward annual dividend yield 42.94%
Trailing annual dividend rate 30.72
Trailing annual dividend yield 31.47%
5-year average dividend yield 42.04
Payout ratio 472.94%
Dividend date 313 May 2024
Ex-dividend date 421 Mar 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 6.61%
Operating margin (ttm)21.41%

Management effectiveness

Return on assets (ttm)8.46%
Return on equity (ttm)8.81%

Income statement

Revenue (ttm)2.88B
Revenue per share (ttm)26.03
Quarterly revenue growth (yoy)11.00%
Gross profit (ttm)N/A
EBITDA 791M
Net income avi to common (ttm)190M
Diluted EPS (ttm)1.70
Quarterly earnings growth (yoy)293.30%

Balance sheet

Total cash (mrq)229M
Total cash per share (mrq)1.04
Total debt (mrq)1.19B
Total debt/equity (mrq)53.92%
Current ratio (mrq)1.57
Book value per share (mrq)9.94

Cash flow statement

Operating cash flow (ttm)608M
Levered free cash flow (ttm)445.25M